Immunization

Only about half of girls immunized against human papillomavirus received the vaccine at the age recommended by the US Centers for Disease Control and Prevention.

The FDA today approved Bexsero, a vaccine to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroup B in patients aged 10 to 25 years.

New research findings on the pathogen behind the flu could increase the effectiveness of influenza immunization programs.

By simulating pertussis resurgences, researchers have identified the immunization schedules that result in the greatest reduction in whooping cough at the lowest economic cost.

Even a hospital pharmacist can be misinformed when it comes to vaccinations and the decision to vaccinate their own child.

Evidence suggesting that this year's flu vaccine missed the mark has caused the CDC to turn to other treatment strategies.

The 7 main adverse outcomes associated with 2 common childhood immunizations are highly unlikely to occur following vaccine administration.

Respiratory syncytial virus infection increases the risk of pneumonia in young children.

While some researchers have associated human papillomavirus vaccination with an increased risk for multiple sclerosis, a new study found no such link between the vaccine and the development of demyelinating disease.

Pharmacies across the country are seeing a shortage in a product many patients use as a defense against the flu.

A new study out of the Mailman School of Public Health and Columbia University Medical Center has found that text message reminders increase the chances that children will receive their second dose of the influenza vaccine.

Long-term care residents benefit more from the high-dose flu vaccine than the regular flu shot.

Flu activity tends to peak in January or later and can sometimes go into May, so it's not too late for individuals to protect themselves by getting vaccinated.

The FDA today approved the human papillomavirus 9-valent vaccine recombinant for the prevention of 5 more types of HPV than the previously approved Gardasil.

In light of new data that shows the 2014-2015 flu season could be severe, the US Centers for Disease Control and Prevention is urging immediate influenza vaccination for all unvaccinated individuals, as well as prompt antiviral drug treatment for those who develop flu and have a high risk of complications.

In support of National Influenza Vaccination Week, Rite Aid is reducing the price of flu shots by $5 to encourage people who have not yet received their annual flu shot to get vaccinated. From now through December 13, flu shots will be available from Rite Aid certified immunizing pharmacists at Rite Aid pharmacies nationwide at a reduced price of only $26.99*, subject to state regulations. Flu shots are covered by most insurance plans, including Medicare Part B.

A powdered measles vaccine delivered by a puff of air triggered no adverse side effects during early human testing, and future clinical trials will likely establish its efficacy.

The first and only FDA-approved vaccine for active immunization to prevent invasive serogroup B meningococcal disease in patients aged 10 to 25 years is now available for order by retail pharmacies.

Thanks to Participating Mutual Member Pharmacies, Over 2700 Vaccines will be donated to children in Haiti for the month of October 2014.

The World Health Organization is criticizing the drug industry for delaying the development of an Ebola vaccine.

The FDA has expanded its approval of Protein Sciences Corp's Flublok influenza vaccine to cover patients aged 50 years and older, thus permitting its use in all adults.

One of the most crucial roles in the fight to stop the spread of Ebola may be played by a mouse.

The FDA today approved the first vaccine licensed in the United States to prevent invasive serogroup B meningococcal disease in patients aged 10 to 25 years.